 Research analysts at Cowen began coverage on shares of Passage Bio NASDAQ:IMRA in a report issued on Monday, Briefing.com Automated Import reports. The brokerage set an outperform rating and a 25.00 price target on the stock. Cowens price target would suggest a potential upside of 56.35 from the stocks previous close. IMRA has been the ... 